Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
08/2005
08/31/2005CN1660310A Plaster of Chinese traditional medicine for treating sleep disorder and preparation method
08/31/2005CN1660291A Chinese materia medica preparation for treating spasm of eye and facial muscles, and preparing method
08/31/2005CN1660257A Soft capsule of extractive from leaves of persimmon and self-emulsifying system for releasing drug
08/31/2005CN1660216A Oral wine agent of Chinese traditional medicine for treating neurasthenia
08/31/2005CN1660191A Oral preparation of Chinese traditional medicine for treating vascular headache and hemicrania, and preparation method
08/31/2005CN1660175A Capsules for nourishing the brain
08/31/2005CN1660165A Production of containing bupleurum root, seed of spine date and soybean isoflavone for improving sleeping, preparation method and application
08/31/2005CN1660154A Extractive and its application in medicine
08/31/2005CN1660146A Fuyankang' soft capsule and preparation method
08/31/2005CN1660126A Medication of combination of sodium cytidine triphosphate and ebselen
08/31/2005CN1660125A New capability and application of soybean isoflavone for enhancing and improving memory
08/31/2005CN1660111A Highly selective norepinephrine reuptake inhibitors and methods of using the same
08/31/2005CN1660110A Highly selective norepinephrine reuptake inhibitors and methods of using the same
08/31/2005CN1660109A Highly selective norepinephrine reuptake inhibitors and methods of using the same
08/31/2005CN1660108A Highly selective norepinephrine reuptake inhibitors and methods of using the same
08/31/2005CN1660106A Combination of inhibiting activity of acetylcholinesterase, preparation method and application
08/31/2005CN1660086A Nasal cavity administration of zolpidem tartrate
08/31/2005CN1660074A Crystalline composition containing escitalopram
08/31/2005CN1660062A Lysine acetic acid in use for injection
08/31/2005CN1660060A Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of hyperuricemia
08/31/2005CN1660056A Oral disintegration tablet of tramadol hydrochloride and preparation method
08/31/2005CN1217190C Modulation of smrl-nep interactions in cns disorders giving rise to mental disorders
08/31/2005CN1216869C Polymorphic crystalline forms of celecoxib
08/31/2005CN1216864C Positive modulators of nicotinic receptor agonists
08/31/2005CN1216858C Carbamate compound and its prepn.
08/31/2005CN1216857C Aniline-derived ligands for thyroid receptor
08/31/2005CN1216856C Novel cyclocompound having cycloalkylene chain, prepn. method and pharmaceutical compositions contg. same
08/31/2005CN1216644C Tin-117m-containing radio therapeutic agents
08/31/2005CN1216639C Methods for treating pain
08/31/2005CN1216629C Chinese medicine for treating epilepsia and preparation method thereof
08/31/2005CN1216621C Medication for nourishing yin and strengthening yang and preparation method
08/31/2005CN1216619C Plaster for treating facial paralysis
08/31/2005CN1216607C Neurotoxicity inhibiting compsns. contg. ginsenoside Rg3 or ginsenoside Rh2 transferring glu
08/31/2005CN1216606C Stable aspirin ointment preparations
08/31/2005CN1216602C Combination of lipoic acids and conjugated acids for treating diabetic disorders
08/31/2005CN1216599C Polyamine treatment of neurological disorders
08/31/2005CN1216594C Suspension comprising oxcarbazepine
08/30/2005US6936720 Method for preparing benzisoxazole methane sulfonyl chloride and its amidation to form zonisamide
08/30/2005US6936715 Lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines
08/30/2005US6936638 for treating or preventing conditions associated with altered mitochondrial function with such compounds eg Alzheimer's Disease; diabetes mellitus; obesity; Parkinson's Disease; Huntington's disease; dystonia; Leber's hereditary optic neuropathy
08/30/2005US6936633 Pyrrolidinone derivatives
08/30/2005US6936631 Bicyclic imidazo-5-yl-amine derivatives
08/30/2005US6936622 they are phosphodiesterase (PDE) inhibitors useful for treament of allergic rhinitis, crohn's disease, ulcerative colitis, rheumatoid arthritis, bronchitis, bronchial asthma, COPD, ARDS, psoriasis, eczema, and combination thereof thereof.
08/30/2005US6936621 Use of benzoylalkyl-1,2,3,6-tetrahydropyridines
08/30/2005US6936617 Nitrogen compounds such as 6-chloro-3-ethyl-2-(2-thiazol-2-yl -imidazol-1-ylmethyl)-imidazo(1,2-b)pyridazine used for prophylaxis of nervous system disorders
08/30/2005US6936613 for treatment of central nervous system diseases and disorders, which are responsive to modulation of the Gamma amminobutyric acid (GABA) receptor complex, and for inducing and maintaining anesthesia, sedation and muscle relaxation
08/30/2005US6936612 2-(Pyridin-2-ylamino)-pyrido[2,3-d]pyrimidin-7-ones
08/30/2005US6936609 Hydrolase enzyme inhibitors comprising nitrogen compounds such as 2-(3,4-Dimethoxyphenyl)-7-(1-ethylpropyl)-5-methyl-4-(3,4,5-trimethoxyphenoxy)-imidazo[5,1-f][1,2,4]triazine, used for prophylaxis of neurodegenerative disorders
08/30/2005US6936608 7-phenylimidazo(1,2-b)(1,2,4)triazine derivatives, substituted at the meta position of the phenyl ring by an optionally substituted aryl or heteroaryl group which is directly attached or bridged by an oxygen atom or a
08/30/2005US6936606 Cyanoamido-containing heterocyclic compounds useful as reversible inhibitors of cysteine proteases
08/30/2005US6936605 Pharmaceutical composition
08/30/2005US6936597 A conjugate of blocked polymer with a biologically active compound containing reactive hydroxy or amino groups
08/30/2005US6936594 Gene therapy for cerebrovascular disorders
08/30/2005US6936285 Use of Ginkgo biloba extracts for preparing a medicine
08/30/2005CA2336968C Quinoline derivatives
08/30/2005CA2195372C A method of preparing the enantiomers of o-demethyltramadol
08/30/2005CA2136331C New pharmaceutical uses of krill enzymes
08/30/2005CA2133152C Piperidines and piperazines with affinity for 5-ht receptors
08/30/2005CA2103887C Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
08/25/2005WO2005077946A1 Dihydrotetrabenazines and pharmaceutical compositions containing them
08/25/2005WO2005077905A1 Fused-ring 4-oxopyrimidine derivative
08/25/2005WO2005077900A1 Bicyclic amide derivatives
08/25/2005WO2005077895A1 Thioamides and salts thereof and cytokine production inhibitors containing both
08/25/2005WO2005077887A1 Novel method of synthesis and novel crystalline form of agomelatine and pharmaceutical compositions containing said form
08/25/2005WO2005077404A1 Use of luteinizing hormone (lh) and chorionic gonadotropin (hcg) for proliferation of neural stem cells and neurogenesis
08/25/2005WO2005077381A1 Use of ginsenoside re for preparation of medicaments for treating dysmnesia
08/25/2005WO2005077359A1 Stabilized pharmaceutical composition containing indoline compound
08/25/2005WO2005020982A3 Using selective antagonists of persistent sodium current to treat neurological disorders and pain
08/25/2005WO2003098385A3 System and method for transparent early detection, warning, and intervention during a medical procedure
08/25/2005US20050187291 use of 2-(urea or thiourea)tetralins as analgesic or to treat pulmonary dysfunction
08/25/2005US20050187290 administering vitamin C or derivatives, as cyclic adenosine monophosphate (cAMP) modulators; demyelination; Charcot-Marie-Tooth disease; genetic disorders
08/25/2005US20050187285 administering anticholesterol agents to inhibit the induction of major histocompatibilty complex (MHC class II) expression by gamma-inteferon (IFN- gamma); treatment of autoimmune diseases
08/25/2005US20050187284 Integrin receptor inhibitors
08/25/2005US20050187282 Condensed indoline derivatives and their use as 5HT, in particular 5HT2c, receptor ligands
08/25/2005US20050187273 Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function
08/25/2005US20050187264 2-Cyano-N-[4-(methoxymethoxy)phenethyl]-3-(3-pyridyl)-2-propenamide: generic derivatives described in WO 99/05109; asthma; bronchitis; rhinitis; vision defects; antiarthritic agents; antiallergens; sepsis; inflammatory bowel disease; bipolar disordes; schizophrenia; Crohn's disease; degenerative joints
08/25/2005US20050187260 2-Pyrrolidin-2-yl-[1,3,4]-oxadiazole compounds and their use as anti-depressants
08/25/2005US20050187255 Novel curcumin analogues and uses thereof
08/25/2005US20050187253 Medicinal kit to quit tobacco consumption comprising central cannabinoid receptor antagonist
08/25/2005US20050187252 Novel compounds as opioid receptor modulators
08/25/2005US20050187238 Benzofuran derivatives, their production and use
08/25/2005US20050187228 Derivatives of purine, their preparation process and pharmaceutical compositions containing them
08/25/2005US20050187226 A1 adenosine receptor antagonists
08/25/2005US20050187225 dissolving in solvent; precipitation; isolation; sleep disorders; sedatives; antiepileptic agents
08/25/2005US20050187220 Alleviating pain, treating a locomotive disorders, stress, depression, epilepsy, Alzheimer's disease, senile dementia, general cognitive dysfunction, drug and alcohol abuse, hypotension, hypertension, tinnitus, pruritus, defective hearing, anorexia, obesity; chemical synthesis
08/25/2005US20050187217 Sodium channel modulators; pain relievers; treating epilepsy, neurodegenerative disorders, psychiatric disorders, arrhythmia, movement disorders, autoimmune diseases, and incontinence; fused ring 4-aminopyrimidines e.g. 4-amino-5,6,7,8-tetrahydroquinazolines
08/25/2005US20050187205 Pyrrolidineacetamide derivative alone or in combination for treatment of CNS disorders
08/25/2005US20050187188 Methods for the treatment of a traumatic central nervous system injury
08/25/2005US20050186663 Cystine-knot fold protein
08/25/2005US20050186650 Pharmaceuticals and methods for treating hypoxia and screening methods therefor
08/25/2005US20050186638 Detecting modulators of brain membrane protein; obtained membrane protein incubated with ligand and labeled compound, measure level of binding
08/25/2005US20050186628 Dorsalin-1 polypeptide and uses thereof
08/25/2005US20050186568 Enzymatic polypeptides for use as drug screening tools; pharmacological toxicity
08/25/2005US20050186559 Identifying Amyloid precurser protein lowering agents; non-steroidal anti-inflammatory drug (NSAID); Alzheimer's disease
08/25/2005US20050186545 Method of constructing spinal injury model monkey and utilization thereof
08/25/2005US20050186288 Compositions and methods for the prophylaxis and treatment of aphthous ulcers and herpes simplex lesions
08/25/2005US20050186287 Use of copper agonists such as divalent metal ions, oligopeptides, oligonucleotides, oligosaccharides, nucleotide analogs that bind to copper binding site of amyloid precursor protein and reduce or prevent release of amyloid A beta peptide; prevention or treatment of Alzheimer's disease
08/25/2005US20050186265 Negatively charged first lipid; barium, calcium, zinc, magnesium and/or cation; carbohydrates, vitamins, minerals, polynucleotides, polypeptides, lipids, flavors and drugs; particle sizes; storage stability, oxidation resistance, dimensional stability;
08/25/2005US20050186250 Metallic structures incorporating bioactive materials and methods for creating the same
08/25/2005US20050186192 Administering the vaccine having attenuated T cells reactive against epitopes of myelin basic protein
1 ... 947 948 949 950 951 952 953 954 955 956 957 958 959 960 961 962 963 964 965 966 967 ... 1833